Managed Care and the Evaluation and Adoption of Emerging Medical Technologies
Abstract
New medical technologies-pharmaceuticals, medical devices, and procedures-often allow major improvements in the outcomes of medical care, but they are also widely believed to be a leading cause of increasing costs. Selective adoption of new technologies, the taking on of only those technologies for which the medical benefits exceed the costs to society of developing and using them, is a crucial element in the quest to control health care costs while preserving or enhancing the quality of care. This report focuses on adoption of innovative medical technologies by managed care organizations (MCOs). The project had two primary objectives: (1) to understand current processes of MCOs for making coverage, medical-necessity, and payment decisions involving emerging medical technologies, and how device developers and manufacturers prepare for and participate in these processes; and (2) to identify ways that private, voluntary action by the managed-care and device industries individually or jointly might improve-for the benefit of society-the processes by which new medical technologies are developed, evaluated, and adopted or rejected for coverage.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 2000
- Accession Number
- ADA378259
Entities
People
- M. S. Ridgely
- Robin Meili
- Roger S. Taylor
- Steven Garber
Organizations
- RAND Corporation